logo
logo
Sign in

Contrast Media Injectors Market 2023 to 2033: Advanced R&D Process Strategies

avatar
Ganesh Shinde
Contrast Media Injectors Market 2023 to 2033: Advanced R&D Process Strategies

The market value of the total contrast media injectors to be sold this year, 2023, is around US$ 1.6 Billion. Furthermore, the global contrast media injector market is predicted to reach approximately US$ 3 Billion by 2033 by following a yearly growth rate of 6.6%.

Increasing trauma cases globally is expected to boost the growth of the contrast media injectors market. Additionally, the increasing prevalence of cancer among the geriatric population globally is expected to drive demand for the contrast media injectors market.

Furthermore, as the number of cancer, neurological, and cardiovascular patients admitted to hospitals rises, the industry will experience significant growth. With the vast range of applications in radiology, interventional radiology, and interventional cardiology, hospitals are the principal users of high-pressure contrast media injectors.

End-user demand for technologically improved contrast media injectors, such as IT-enabled contrast media injectors that can connect to a hospital database for dosage monitoring, is driving up contrast media injector prices.

Air emboli formed during contrast media injection can restrict right ventricular outflow or clog pulmonary arterioles, resulting in significant complications such as cardiovascular collapse.

Competitive Landscape for the Contrast Media Injectors Market

Some of the key players operating in the global media injectors market are Bayer AG, NemotoKyorindo Co. Ltd., Mallinckrodt, Bracco Imaging, Ulrich GmBh, Guerbet SA, Medtronic AG, Sino Medical-device Technology Co., Ltd, and Apollo RT Co., Ltd among others.

Recent Developments in the Contrast Media Injectors Industry

  • In May 2021, Bayer AG announced a collaboration with ArcherDX, Inc., which will focus on the global development and commercialization of therapy-accompanying diagnostic tests – also known as companion diagnostics (CDx) – for Vitrakvi™ (larotrectinib), based on next-generation sequencing.
  • In May 2019, the Ulrich’s CT contrast agent injector, CT motion, was made available in the world's most important medical technology market, the US

Know More About Report@ https://www.futuremarketinsights.com/reports/contrast-media-injectors-market

Contrast Media Injectors Market by Category

By Product Type:

  • CT Injectors
  • MRI Injectors
  • Cardio Injectors

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostics Centers
  • Others


collect
0
avatar
Ganesh Shinde
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more